Clorox (CLX) PT Raised to $171 at Citi
Tweet
Share
E-mail
Get Alerts CLX Hot Sheet
Price: $97.09 -0.46%
Rating Summary:
2 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 110
Rating Summary:
2 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 110
Join SI Premium – FREE
Citi analyst Wendy Nicholson raised the price target on Clorox (NYSE: CLX) to $171.00 (from $169.00) while maintaining a Neutral rating following model updates.
Nicholson maintained FY19 EPS estimate of $6.30. She also maintained FY20 EPS estimate of $6.70 and FY21 EPS estimate of $7.10.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'
- Kymera Therapeutics (KYMR) PT Raised to $136 at Truist Securities
- Universal Technical Institute (UTI) PT Raised to $47 at Truist Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
